China's WuXi PharmaTech ($WX) has completed work on a biologics safety testing facility in Suzhou, adding 38,000 square feet of lab space to its sprawling presence in the area. The new facility is right next to the CRO's preclinical safety testing operation, and WuXi expects it to come online this summer. More